A Novel Pathogenic HSPG2 Mutation in Schwartz–Jampel Syndrome

Po Yu Lin, Jia Horung Hung, Chao Kai Hsu, Yao Tsung Chang, Yuan Ting Sun

研究成果: Article同行評審

摘要

Schwartz–Jampel syndrome is a rare autosomal recessive disease caused by mutation in the heparan sulfate proteoglycan 2 (HSPG2) gene. Its cardinal symptoms are skeletal dysplasia and neuromuscular hyperactivity. Herein, we identified a new pathogenic mutation site (NM_005529.6:c.1125C>G; p.Cys375Trp) of HSPG2 leading to Schwartz–Jampel syndrome by whole-exome sequencing. This mutation carried by the asymptomatic parents was previously registered in a single-nucleotide polymorphism database of the National Institutes of Health as a coding sequence variant rs543805444. The pathogenic nature of this missense mutation was demonstrated by in silico pathogenicity assessment, clinical presentations, and cellular function of primary fibroblast derived from patients. Various in silico software applications predicted the mutation to be pathogenic [Sorting Intolerant From Tolerant (SIFT), 0; Polyphen-2, 1; CADD (Combined Annotation Dependent Depletion), 23.7; MutationTaster, 1; DANN (deleterious annotation of genetic variants using neural networks); 0.9]. Needle electromyography revealed extensive complex repetitive discharges and multiple polyphasic motor unit action potentials in axial and limb muscles at rest. Short exercise test for myotonia showed Fournier pattern I. At cellular levels, mutant primary fibroblasts had reduced levels of secreted perlecan and impaired migration ability but normal capability of proliferation. Patients with this mutation showed more neuromuscular instability and relatively mild skeletal abnormality comparing with previously reported cases.

原文English
文章編號632336
期刊Frontiers in Neurology
12
DOIs
出版狀態Published - 2021 三月 9

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

指紋 深入研究「A Novel Pathogenic HSPG2 Mutation in Schwartz–Jampel Syndrome」主題。共同形成了獨特的指紋。

引用此